StonvexLoading…
StonvexStonvexStonvexCore line items from PETS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-12-31 | Annual 2024 2024-09-30 | Annual 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $226.97M | $176.21M | $124.25M | $66.21M |
Operating Income | $-1.53M | Not available | Not available | Not available |
Net Income | $-6.27M | Not available | Not available | Not available |
EPS (Diluted) | $-0.30 | Not available | Not available | Not available |
Total Assets | $148.70M | Not available | Not available | Not available |
Total Liabilities | $63.57M | Not available | Not available | Not available |
Cash & Equivalents | $54.72M | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | $-395.00K | Not available | Not available | Not available |
Shares Outstanding | 20.66M | Not available | Not available | Not available |